Steven P. Hulme - Feb 28, 2022 Form 4 Insider Report for Ingevity Corp (NGVT)

Role
SVP, Perf Chem and Pres, EP
Signature
Steven Hulme By: Mavis Huger as Attorney-in-Fact
Stock symbol
NGVT
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 11:44 AM
Previous filing
Jan 10, 2022
Next filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGVT Common Stock Award $0 +1.46K $0.00 1.46K Feb 28, 2022 Common Stock 1.46K $68.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably on February 28, 2023, 2024 and 2025.